- Home
- MLKN vs SPRY Comparison
MLKN vs SPRY Comparison
Compare MLKN & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- SPRY
- Stock Information
- Founded
- MLKN 1905
- SPRY 2015
- Country
- MLKN United States
- SPRY United States
- Employees
- MLKN N/A
- SPRY N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- MLKN Consumer Discretionary
- SPRY Health Care
- Exchange
- MLKN Nasdaq
- SPRY Nasdaq
- Market Cap
- MLKN 1.0B
- SPRY 1.2B
- IPO Year
- MLKN N/A
- SPRY N/A
- Fundamental
- Price
- MLKN $16.78
- SPRY $13.44
- Analyst Decision
- MLKN
- SPRY Strong Buy
- Analyst Count
- MLKN 0
- SPRY 4
- Target Price
- MLKN N/A
- SPRY $28.75
- AVG Volume (30 Days)
- MLKN 471.1K
- SPRY 1.2M
- Earning Date
- MLKN 06-25-2025
- SPRY 05-14-2025
- Dividend Yield
- MLKN 4.48%
- SPRY N/A
- EPS Growth
- MLKN N/A
- SPRY N/A
- EPS
- MLKN 0.43
- SPRY 0.08
- Revenue
- MLKN $3,597,000,000.00
- SPRY $89,149,000.00
- Revenue This Year
- MLKN $1.97
- SPRY $1.49
- Revenue Next Year
- MLKN $3.05
- SPRY $141.68
- P/E Ratio
- MLKN $39.33
- SPRY $168.31
- Revenue Growth
- MLKN N/A
- SPRY 297063.34
- 52 Week Low
- MLKN $15.25
- SPRY $7.55
- 52 Week High
- MLKN $31.73
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- MLKN 48.68
- SPRY 46.69
- Support Level
- MLKN $15.77
- SPRY $13.06
- Resistance Level
- MLKN $16.78
- SPRY $15.06
- Average True Range (ATR)
- MLKN 0.53
- SPRY 0.67
- MACD
- MLKN 0.19
- SPRY -0.18
- Stochastic Oscillator
- MLKN 88.33
- SPRY 15.97
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.